We've been talking about talking about peer supports and recovery coaches for more than a decade. The use of para-professionals in the field goes back several decades. Now, a new study evaluates a similar role for enhancing management of other chronic diseases. Disease Management Care Blog provides a little analysis: There is increasing interest in incorporating lay-persons in the outpatient … Continue reading Recovery coaches for chronic disease management
Category: Research
“It works!”, Ctd
A new study of buprenorphine implants find that implants work as well as oral dosing and outperform placebo. What does that mean? If I'm reading it correctly, it means that the average subject receiving the implant tested positive for opioids 68.8% of the time compared to 86.6% for the placebo subjects. (If I'm misreading it, … Continue reading “It works!”, Ctd
Recovery for life?
Our friend Bill White has been blogging. This is great news! To my mind, he's been the most important voice in addiction treatment, recovery and research of both. His writing is very accessible and he bridges experiential knowledge and empirical knowledge. He's also been amazingly prolific. The downside of this is that his body of work … Continue reading Recovery for life?
What happened to the “crack babies”?
Dirk Hansen reports the good news about "crack babies": In a paper authored by Hurt, Laura M Betancourt, and others, the investigators write: “It is now well established that gestational cocaine exposure has not produced the profound deficits anticipated in the 1980s and 1990s, with children described variably as joyless, microcephalic, or unmanageable.” The authors do … Continue reading What happened to the “crack babies”?
Cash, sexual favors and drugs
Cash, sexual favors and drugs. We're not talking about a dope house. Some people (and companies) never learn: ...last week, UK pharma firm GlaxoSmithKline admitted that Chinese doctors were bribed by its execs with cash and sexual favours in return for prescribing the company's drugs. That coincided with rival AstraZeneca having its Shanghai office raided … Continue reading Cash, sexual favors and drugs
Buprenorphine + therapy = ?
Ian McLoone directs us to another study (the 4th in a row) finding that buprenorphine patients receive no benefit from added behavioral treatments. Where does this leave us? We've seen criticism of the devolution of methadone maintenance (MMT) into dosing clinics with calls for a new recovery orientation to MMT and a return to methadone being … Continue reading Buprenorphine + therapy = ?
Sentences to ponder
As a result of this research, AA as an organization has experienced an "empirical awakening," evolving from its peripheral status as a "nuisance variable" and perceived obstacle to progress to playing a more central role in a scientifically informed recovery oriented system of care. Also, professionally delivered interventions designed to facilitate the use of AA … Continue reading Sentences to ponder
Buprenorphine and emotional reactivity
The following article was shared with me by a reader. Not surprisingly, the emphasized portion below caught my eye. [emphasis mine] Abstract Addictions to illicit drugs are among the nation’s most critical public health and societal problems. The current opioid prescription epidemic and the need for buprenorphine/naloxone (Suboxone®; SUBX) as an opioid maintenance substance, and its … Continue reading Buprenorphine and emotional reactivity
What makes treatment effective?
I've been catching a lot of heat recently for posts about Suboxone and methadone. (For the sake of this post, lets refer to them as opioid replacement therapy, or ORT, for the rest of this post. One commenter who blogs for an ORT provider challenged my arguments that we should offer everyone the same kind … Continue reading What makes treatment effective?
Why “medical” marijuana gets little respect here
Mark Kleiman, the Washington state pot czar, explains his use of "scare quotes" when writing about medical marijuana: Yes, cannabis has medical value for some people. And yes, the sustained effort of the federal government to make medical cannabis research as difficult as possible is a national disgrace. And then, on the other … Continue reading Why “medical” marijuana gets little respect here
